Don’t miss the ISA deadline! Here’s 2 FTSE 100 stocks I’m keen to buy for my 2020 ISA allocation

Jonathan Smith explains why he is eyeing up both GlaxoSmithKline and Pennon Group for his 2020 ISA allocation.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every year, the ISA deadline comes around bizarrely quickly. This year, due to the Covid-19 pandemic, the deadline on 5 April probably has slipped your mind as well. This is not only a friendly reminder about the deadline from a fellow forgetful investor, but also some of my suggestions.

Firstly, I wanted to mention why it is important to utilize your ISA despite everything going on in the world at the moment. The deadline is this week, but the impact of meeting the deadline will benefit you for at least the next year.

This is because your investments that are sheltered within the allocation are tax-free. This is a longer term benefit. If you buy a stock this week for the ISA, and sell it in five year for a 25% profit, that profit is free of tax. So even if it does not seem a priority right this second, your future self will be very thankful!

Old school

A tried and tested stock is GlaxoSmithKline (LSE: GSK). It is one of the largest pharmaceutical companies in the world, and is also a regular in the top 10 largest capitalized firms in the FTSE 100 index. 

Share price performance of the firm has been steady over the past decade, and this is why I would look to add it into an ISA. GSK is never going to be a share that massively deviates from a steadily increasing mean price. What I mean by this is that it does not have very large price swings in the short term. This is good for investors who want to be able to sleep easily at night.

The reason I would look to buy it for this ISA allocation is due to the market sell-off we have seen as a result of the Covid-19 pandemic. GSK has seen an uncharacteristically large sell-off, down around 23% from the 2020 peak. Given that I think the firm’s products are going to be more in demand, I would expect the share price to reverse higher. The dislocation in the current price versus my expectations makes it a long-term buy in my opinion. 

New kid

One of the firms due for promotion into the FTSE 100 is Pennon Group (LSE: PNN). It is a utility firm that operates mostly under the brands South West Water and Viridor. The company has performed very well over the past year, with a share price jump of over 30%. South West Water provides water for Devon and Cornwall. Viridor operates in the waste management space, serving a similar set of customers.

The reason I would be adding this into my ISA allocation for this year is that it is a defensive stock. Utilities and waste management are services that are staples for consumers. So I feel this stock protects me even if the situation with Covid-19 continues for another year. The revenues and profits from Pennon should be largely unaffected by the virus. Given is also has momentum following a strong year in 2019, it appeals to me right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jonathan Smith does not own shares in any firm mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Pennon Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »